There is a commonly held view that the protection of transgenic animals does not raise specific concerns and is adequately covered by existing controls on laboratory animal production and use, and that the transfer of genes among species, which is said to be a naturally occurring event in any case, does not involve any particular moral dilemmas. I do not share that opinion, nor did the authors of the ECVAM workshop report on The Use of Transgenic Animals in the European Union,1 which contained 39 conclusions and 14 recommendations, and is reproduced in full in this special issue of ATLA.
Mark T.D. Cronin, John F. Garrod and Michael Balls
The White Paper (1) that eventually became the REACH legislation (2) stimulated much comment in the scientific and non-scientific media (e.g. 3). Early in the consideration of the White Paper, it was realised that to test all chemicals likely to be covered by the REACH system was not only unrealistic in the timeframe of the legislation, but was also ethically indefensible.